Predictors of outcome of pharmacological and psychological treatment of late-life panic disorder with agoraphobia.

Author: HendriksGert-Jan, HoogduinCees A L, KampmanMirjam, KeijsersGer P J, Oude VoshaarRichard C

Paper Details 
Original Abstract of the Article :
OBJECTIVE: This study aims to evaluate the differential predictive values of age, age of onset and duration of illness on paroxetine and cognitive-behavioural therapy (CBT) outcome in late-life panic disorder with agoraphobia. METHOD: Patients 60 years and older with a confirmed diagnosis of panic ...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元:
https://doi.org/10.1002/gps.2700

データ提供:米国国立医学図書館(NLM)

Decoding the Predictors of Panic Disorder Treatment Success in Older Adults

Panic disorder with agoraphobia, characterized by intense fear and avoidance of situations that might trigger panic attacks, can be particularly challenging for older adults. This research investigates the factors that influence the outcomes of pharmacological and psychological treatments for late-life panic disorder with agoraphobia. The study examined the predictive values of age, age of onset, and duration of illness in a group of 49 patients aged 60 years and older. Patients were randomly assigned to receive either paroxetine, cognitive-behavioral therapy (CBT), or a waiting-list control condition.

Age and Illness Duration: Key Predictors for Treatment Success

The study revealed that a later age of onset and shorter duration of illness were associated with more favorable outcomes following CBT. However, these factors did not influence the effectiveness of paroxetine treatment. The findings suggest that CBT may be a more effective treatment option for older adults with a later age of onset or a shorter duration of illness, while paroxetine may be better suited for individuals with an early onset and longer duration of illness.

Navigating Panic Disorder in Later Life: Tailored Treatment Approaches

This study underscores the importance of tailoring treatment approaches for panic disorder with agoraphobia in older adults. Considering factors such as age of onset and duration of illness can help guide treatment decisions and improve the likelihood of successful outcomes. Remember, just as a camel adapts its behavior to the changing desert landscape, we must be mindful of individual factors and tailor treatment strategies accordingly. Consulting with a qualified healthcare professional is essential for receiving personalized guidance and support.

Dr. Camel's Conclusion

This research provides valuable insights into the factors that influence the effectiveness of different treatment approaches for late-life panic disorder with agoraphobia. The findings highlight the importance of individualized treatment plans that consider factors like age of onset and duration of illness. Remember, just as a camel navigates the desert with agility and adaptability, we can approach the challenges of mental health with personalized care and a commitment to finding the most effective treatment strategies.

Date :
  1. Date Completed 2012-03-01
  2. Date Revised 2022-12-07
Further Info :

Pubmed ID

21452176

DOI: Digital Object Identifier

10.1002/gps.2700

Related Literature

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.